144 related articles for article (PubMed ID: 24590133)
1. Imaging: reducing ionizing radiation in children and adolescents.
Hutchinson L
Nat Rev Clin Oncol; 2014 Apr; 11(4):178. PubMed ID: 24590133
[No Abstract] [Full Text] [Related]
2. (18)F-FDG PET/CT scans for children and adolescents.
Lassmann M; Eberlein U; Tosi G; Chiti A
Lancet Oncol; 2014 Jun; 15(7):e243-4. PubMed ID: 24872098
[No Abstract] [Full Text] [Related]
3. (18)F-FDG PET/CT scans for children and adolescents - authors' reply.
Daldrup-Link H; Quon A; Goske M
Lancet Oncol; 2014 Jun; 15(7):e244. PubMed ID: 24872100
[No Abstract] [Full Text] [Related]
4. Can whole-body MRI replace (18)F-fluorodeoxyglucose PET/CT?
Kwee TC
Lancet Oncol; 2014 Mar; 15(3):243-4. PubMed ID: 24559804
[No Abstract] [Full Text] [Related]
5. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
Klenk C; Gawande R; Uslu L; Khurana A; Qiu D; Quon A; Donig J; Rosenberg J; Luna-Fineman S; Moseley M; Daldrup-Link HE
Lancet Oncol; 2014 Mar; 15(3):275-85. PubMed ID: 24559803
[TBL] [Abstract][Full Text] [Related]
6. Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.
Noij DP; Boerhout EJ; Pieters-van den Bos IC; Comans EF; Oprea-Lager D; Reinhard R; Hoekstra OS; de Bree R; de Graaf P; Castelijns JA
Eur J Radiol; 2014 Jul; 83(7):1144-1151. PubMed ID: 24768188
[TBL] [Abstract][Full Text] [Related]
7. Can diffusion-weighted whole-body MRI replace contrast-enhanced CT for initial staging of Hodgkin lymphoma in children and adolescents?
Regacini R; Puchnick A; Luisi FAV; Lederman HM
Pediatr Radiol; 2018 May; 48(5):638-647. PubMed ID: 29362839
[TBL] [Abstract][Full Text] [Related]
8. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
[TBL] [Abstract][Full Text] [Related]
9. Comparison between whole-body MRI with diffusion-weighted imaging and PET/CT in staging newly diagnosed FDG-avid lymphomas.
Albano D; Patti C; La Grutta L; Agnello F; Grassedonio E; Mulè A; Cannizzaro G; Ficola U; Lagalla R; Midiri M; Galia M
Eur J Radiol; 2016 Feb; 85(2):313-8. PubMed ID: 26781135
[TBL] [Abstract][Full Text] [Related]
10. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy.
Takenaka D; Ohno Y; Matsumoto K; Aoyama N; Onishi Y; Koyama H; Nogami M; Yoshikawa T; Matsumoto S; Sugimura K
J Magn Reson Imaging; 2009 Aug; 30(2):298-308. PubMed ID: 19629984
[TBL] [Abstract][Full Text] [Related]
11. The role of functional imaging in colorectal cancer.
Figueiras RG; Goh V; Padhani AR; Naveira AB; Caamaño AG; Martin CV
AJR Am J Roentgenol; 2010 Jul; 195(1):54-66. PubMed ID: 20566797
[TBL] [Abstract][Full Text] [Related]
12. 2-[Fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience.
Komori T; Narabayashi I; Matsumura K; Matsuki M; Akagi H; Ogura Y; Aga F; Adachi I
Ann Nucl Med; 2007 Jun; 21(4):209-15. PubMed ID: 17581719
[TBL] [Abstract][Full Text] [Related]
13. Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients.
Abdulqadhr G; Molin D; Aström G; Suurküla M; Johansson L; Hagberg H; Ahlström H
Acta Radiol; 2011 Mar; 52(2):173-80. PubMed ID: 21498346
[TBL] [Abstract][Full Text] [Related]
14. How to comprehend the meaning of ADC value on DWI sequence.
Meng J; Zhang G; Liang W; Xu S
Eur J Radiol; 2012 Apr; 81(4):e697. PubMed ID: 21466930
[No Abstract] [Full Text] [Related]
15. [Whole body diffusion-weighted MR: technique, usefulness and general applications].
La Folie T; Gabaudan C; Triaire B; Richez P; Briant JF
J Radiol; 2008 May; 89(5 Pt 1):603-5. PubMed ID: 18535505
[No Abstract] [Full Text] [Related]
16. [Whole-body diffusion-weighted magnetic resonance imaging in oncology].
Jouvet JC; Thomson V; Durupt F; Bakir M; Berthezene Y
Presse Med; 2010 May; 39(5):548-52. PubMed ID: 19932000
[TBL] [Abstract][Full Text] [Related]
17. Whole-body MRI and PET-CT in the management of cancer patients.
Schmidt GP; Haug AR; Schoenberg SO; Reiser MF
Eur Radiol; 2006 Jun; 16(6):1216-25. PubMed ID: 16538426
[TBL] [Abstract][Full Text] [Related]
18. [Preliminary study on the validity of whole body diffusion-weighted imaging for the detection of malignant lesions].
Wang JW; Zhao S; Liu Y; Li J; Xu LM
Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):304-8. PubMed ID: 20510086
[TBL] [Abstract][Full Text] [Related]
19. Whole-body MRI and FDG PET fused images for evaluation of patients with cancer.
Domingues RC; Carneiro MP; Lopes FC; Domingues RC; da Fonseca LM; Gasparetto EL
AJR Am J Roentgenol; 2009 Apr; 192(4):1012-20. PubMed ID: 19304708
[TBL] [Abstract][Full Text] [Related]
20. Focal thyroid incidentaloma on whole body fluorodeoxyglucose positron emission tomography/computed tomography in known cancer patients: A case-based discussion with a series of three examples.
Targe M; Basu S
J Cancer Res Ther; 2015; 11(4):1029. PubMed ID: 26881609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
